Company news
DX & VX Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Dx&Vx Signs Two Material Transfer Agreements in Latin America Within Two Months -- "Technology Validated Across Both Public and Private Sectors"
August 10, 2026
COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients
September 26, 2025
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
August 18, 2025
Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company
July 30, 2025
Dx&Vx Accelerates Development of Universal COVID-19 Vaccine
May 29, 2025